Skip to main content
. 2018 Apr 6;9:697. doi: 10.3389/fimmu.2018.00697

Table 1.

Lineage tracing models and marker to distinguish microglia and monocyte-derived macrophages in the brain.

Approach Cell type specificity Principle Advantages Limitations Reference
(a) Transplantation models

BMT; TBI BMDM HSC source of blood monocytes is replaced with modified/labeled HSCs High chimerism
No time consuming crossing into genetic disease models
Variability in myeloablation and reconstitution
Artificial engraftment of BM cells in the CNS
(113)

BMT; HPI BMDM HSC source of blood monocytes is replaced with modified/labeled HSCs High chimerism
No time consuming crossing into genetic disease models
Variability in myelo-ablation and reconstitution (37, 113)

BMT; Busulfan BMDM HSC source of blood monocytes is replaced with modified/labeled HSCs High chimerism
No time consuming crossing into genetic disease modelsChemical myeloablation
No irradiation
Variability in myeloablation and reconstitution (112)

Parabiosis BMDM HSC source of blood monocytes is replaced with modified/labeled HSCs Constant influx of donor cells
No myeloablationrequired
No time consuming crossing into genetic disease models
Technically challengingLow chimerism (39)

(b) Genetic lineage tracing models

Ccr2RFP/wt;
Cx3cr1GFP/wt
Monocytes (red)
MG (green)
Differential labeling of Cx3cr1hi:
Ccr2neg MG (green) and of Cx3cr1lo:Ccr2hi monocytes (red)
MG and monocytes contain reporter for labeling Recruitment to the brain leads to increased Cx3cr1 levels in monocyte-derived macrophages
Ccr2 expression is downregulated in monocyte-derived macrophage upon differentiation
(114, 115)

Flt3-Cre Monocytes and HSC-derived monocyte precursors Label/modification induced in Flt3+ monocyte precursors Useful for lineage tracing of myeloid precursors
Useful complementary approach to MG restricted lineage tracing
Cre expression or transmittance restricted to male mice (118)

Cx3cr1-CreER MG Recombination is induced in all Cx3cr1+ cells upon tamoxifen pulse. Long-living MG retain the label/modification. While monocytes vanish and are replenished from precursors that were generated after Cre recombination in response to the tamoxifen pulse Long-term labeling/modification is restricted to MG Spontaneous modification reported in one model
Low recombination in mMF (40–50%)
(42)

Sall1-CreER MG Label/modification induced in Sall1+ MG Sall1 expression is stable also in response to different stimuli Targeting of non-hematopoietic cells in the liver, heart and kidney (119)

(c) Cell-type restricted marker expression

CD45 MGlo
BMDMhi
MG display lower surface expression No requirement for combination of several markers Activated in MG upregulate CD45
BMDM in brain malignancies downregulate CD45
(112, 113, 120)

Tmem119P2ry12Siglech MGhi
BMDMlo
MG show high expression Applicable for mouse and human Downregulation in MG during activation
BMDM in GBM show increased expression
(58, 94, 112)

Sall1 MGhi
BMDMlo
MG show high expression Applicable for mouse and human
Stable expression level at different activation levels
Low expression found on non-leukocytes in the liver, heart, and kidney (119)

Itga4/Cd49d MGlo
BMDMhi
BMDM show high expression Applicable for mouse and human
Stable expression level at different activation levels
Expression found on T cells (112)

BMT, bone marrow transplantation; TBI, total body irradiation; HPI, head protected irradiation; BMDM, bone marrow-derived macrophage; HSC, hematopoietic stem cell; MG, microglia; BM, bone marrow; CNS, central nervous system.